January 15, 2024
More than half of adults with moderate to severe UC maintained clinical and endoscopic remission at 4 years; nearly all no longer required corticosteroids, authors reported.
January 12, 2024
While the FDA's preliminary evaluation has not surfaced evidence of a link, the agency says it "cannot definitively rule out that a small risk may exist," and so will continue research.
January 11, 2024
Use of dupilumab also eliminated the need for use of a rescue inhaler in more than one-third of treated patients and the number of inhalations needed for others.
January 10, 2024
The risk of severe CV events, including leading to death, was greatest in the first week following an exacerbation but remained significantly elevated 1 year later.
January 09, 2024
The novel nonhormonal compound significantly reduced vasomotor symptoms and sleep disturbance while improving quality of life, according to findings.
January 09, 2024
Cannabis use during pregnancy, particularly continued use beyond the first trimester, was associated with SGA birth, still birth, and hypertensive disorders of pregnancy, authors reported.
January 08, 2024
After hospital discharge, persons who had COVID-19 remained at greater risk of death and myriad adverse health outcomes compared with those who had seasonal flu.
January 08, 2024
Individuals with "lean NAFLD" may be at similar risk of NASH, cirrhosis, nonliver cancer, and death as as those with NAFLD and overweight or obesity, authors say.
January 05, 2024
Older adults with a history of migraine, in contrast, were at no greater risk of an automotive crash than those without prevalent migraine, according to new study results.
January 05, 2024
In an open letter to the public, Lilly decries use of tirzepatide products Mounjaro and Zepbound for nonmedical purposes and warns of counterfeit formulations.